Skip to main content
Genitourinary Medicine logoLink to Genitourinary Medicine
. 1992 Jun;68(3):174–176. doi: 10.1136/sti.68.3.174

The value of treating the sexual partners of women with recurrent vaginal candidiasis with ketoconazole.

I W Fong 1
PMCID: PMC1194850  PMID: 1607194

Abstract

OBJECTIVE--To determine whether treatment of the sexual partners of women with chronic vulvovaginal candidiasis with oral ketoconazole can reduce the recurrence rate of candida vaginitis. DESIGN--Single blind randomised study where all the women were treated with ketoconazole 400 mg daily for 7 days after an acute episode of candida vaginitis and half the male partners were treated with ketoconazole 200 mg daily for 5 days. SETTING--Women's Candida Clinic of St. Michael's Hospital, a University of Toronto teaching Hospital, Toronto, Ontario, Canada. SUBJECTS--Fifty-four women attending the clinic with at least four proven episodes of candida vaginitis and their male sex partners (stable monogamous relationships) were enrolled in the study. MAIN OUTCOME MEASURES--Clinical recurrence of candida vaginitis with confirmation by smear and culture. Follow-up was obtained one to two weeks after initial treatment, then monthly for one year. RESULTS--In the control group (untreated partners), 20 of 28 (71%) patients had recurrences in six months, versus 17 of 26 (65%) patients in the treated group (treated partners) (95% Confidence Interval (CI) for the difference in recurrence rate = -19% to 31%). At one year, 23 of 28 (82%) patients in the control group had recurrences, versus 22 of 26 (85%) in the treated group (CI = -23% to 17%). CONCLUSION--Treatment of the male partners, with a brief course of ketoconazole, is not of value in reducing the incidence of relapse in women with recurrent vaginal candidiasis. It is unlikely that a larger study would show a clinical important difference.

Full text

PDF
174

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buch A., Skytte Christensen E. Treatment of vaginal candidosis with natamycin and effect of treating the partner at the same time. Acta Obstet Gynecol Scand. 1982;61(5):393–396. doi: 10.3109/00016348209156578. [DOI] [PubMed] [Google Scholar]
  2. Davidson F. Yeasts and circumcision in the male. Br J Vener Dis. 1977 Apr;53(2):121–122. doi: 10.1136/sti.53.2.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fleury F. J. Recurrent Candida vulvovaginitis. Chemotherapy. 1982;28 (Suppl 1):48–50. doi: 10.1159/000238152. [DOI] [PubMed] [Google Scholar]
  4. Miles M. R., Olsen L., Rogers A. Recurrent vaginal candidiasis. Importance of an intestinal reservoir. JAMA. 1977 Oct 24;238(17):1836–1837. doi: 10.1001/jama.238.17.1836. [DOI] [PubMed] [Google Scholar]
  5. Milne J. D., Warnock D. W. Effect of simultaneous oral and vaginal treatment on the rate of cure and relapse in vaginal candidosis. Br J Vener Dis. 1979 Oct;55(5):362–365. doi: 10.1136/sti.55.5.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Rodin P., Kolator B. Carriage of yeasts on the penis. Br Med J. 1976 May 8;1(6018):1123–1124. doi: 10.1136/bmj.1.6018.1123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Rohatiner J. J. Relationship of Candida albicans in the genital and anorectal tracts. Br J Vener Dis. 1966 Sep;42(3):197–200. doi: 10.1136/sti.42.3.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Schnell J. D. Investigations into the pathoaetiology and diagnosis of vaginal mycoses. Chemotherapy. 1982;28 (Suppl 1):14–21. doi: 10.1159/000238147. [DOI] [PubMed] [Google Scholar]
  9. Sobel J. D. Management of recurrent vulvovaginal candidiasis with intermittent ketoconazole prophylaxis. Obstet Gynecol. 1985 Mar;65(3):435–440. [PubMed] [Google Scholar]
  10. Syverson R. E., Buckley H., Gibian J., Ryan G. M., Jr Cellular and humoral immune status in women with chronic Candida vaginitis. Am J Obstet Gynecol. 1979 Jul 15;134(6):624–627. doi: 10.1016/0002-9378(79)90641-0. [DOI] [PubMed] [Google Scholar]
  11. TORACK R. M. Fungus infections associated with antibiotic and steroid therapy. Am J Med. 1957 Jun;22(6):872–882. doi: 10.1016/0002-9343(57)90023-2. [DOI] [PubMed] [Google Scholar]
  12. Witkin S. S., Yu I. R., Ledger W. J. Inhibition of Candida albicans--induced lymphocyte proliferation by lymphocytes and sera from women with recurrent vaginitis. Am J Obstet Gynecol. 1983 Dec 1;147(7):809–811. doi: 10.1016/0002-9378(83)90044-3. [DOI] [PubMed] [Google Scholar]

Articles from Genitourinary Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES